Importantly, an endogenous co-IP assay in RCC cells revealed that AKT activation attenuated PRR11 interactions with FBXW7 and GSK3β, whereas AKT inactivation strengthened these interactions (Figure 6F and Figure S9D). The gene discussed is GSK3B; the disease is renal cell carcinoma.